Medication info
Augmentin Tablets 375 milligrams (Amoxicillin - Clavulanate Potassium (2:1))

Augmentin Tablets 375 milligrams (Amoxicillin - Clavulanate Potassium (2:1))

Prescription medicationTabletOral
Ingredient · strength
Amoxicillin·Clavulanate Potassium (2:1)›375mg / 1 tablet
Manufacturer / importer
Il Sung IS Co., Ltd.
Appearance
It is a white or nearly white, oval-shaped film-coated tablet.
Packaging
100 tablets (10 tablets/PTPX10)
Approval status
Active

MFDS item code 198500834 · Notified 1985.11.15 · Insurance code 655401500

Summary

Main use
Treatment of respiratory infections, genitourinary infections, and other infections (e.g., skin, bone, and dental infections)
Who takes it
Adults · Children
Adult dose
The dose is determined according to the patient's age, body weight, renal function, and the severity of the infection. Administer at the beginning of a meal to minimize potential gastrointestinal intolerance. Absorption of amoxicillin/clavulanate is optimized when administered at the beginning of a meal. Adults: Administer 250 mg/125 mg of amoxicillin/potassium clavulanate per dose orally 3 times daily, every 8 hours. For severe infections and respiratory tract infections, the dose may be increased to 500 mg/125 mg of amoxicillin/potassium clavulanate per dose. For patients with renal impairment, adjust the dose as appropriate according to creatinine clearance. Adults: Dose adjustment is based on the maximum recommended dose of amoxicillin. No dose adjustment is required for patients with a creatinine clearance (CrCl) of 30 mL/min or more. 10 ~ 30 mL/min Administer 250mg/125mg or 500mg/125mg of amoxicillin/potassium clavulanate per dose every 12 hours. 10 mL/min or less Administer 250mg/125mg or 500mg/125mg of amoxicillin/potassium clavulanate per dose every 24 hours. Hemodialysis Administer 250mg/125mg or 500mg/125mg of amoxicillin/potassium clavulanate per dose every 24 hours, with an additional dose during dialysis and a repeat dose at the end of dialysis. (Both serum amoxicillin and clavulanate concentrations decrease.)
Child dose
Children 12 years of age or older or weighing 40 kg or more: Administer 250 mg/125 mg of amoxicillin/potassium clavulanate per dose orally 3 times daily, every 8 hours. For severe infections and respiratory tract infections, the dose may be increased to 500 mg/125 mg of amoxicillin/potassium clavulanate per dose. Children: Reduce the dose using the same method.

Ingredients

Manufacturer
Il Sung IS Co., Ltd.

Efficacy & effects

Treatment of respiratory infections, genitourinary infections, and other infections (e.g., skin, bone, and dental infections)

  • Acute and chronic bronchitis
  • lobar pneumonia
  • bronchopneumonia
  • empyema
  • lung abscess
  • tonsillitis
  • sinusitis
  • otitis media
  • cystitis
  • urethritis
  • pyelonephritis
  • pelvic infections
View approved original text

This medication is effective against various bacteria and is used for treating symptoms of various respiratory infections such as acute and chronic bronchitis, pneumonia, empyema, and lung abscesses. It is also beneficial for upper respiratory infections such as tonsillitis, sinusitis, and otitis media. It is used in the treatment of urinary tract infections including cystitis, urethritis, and pyelonephritis, and is effective in treating sexually transmitted diseases, such as pelvic infections and gonorrhea. It is also used to treat skin and soft tissue infections like boils, abscesses, wound infections, and osteomyelitis. Furthermore, it is utilized for dental infections, aiding in the healing of various infectious diseases. Overall, it is widely used for the treatment of bacterial infections in multiple areas.

How to take

Adult dose

The dose is determined according to the patient's age, body weight, renal function, and the severity of the infection. Administer at the beginning of a meal to minimize potential gastrointestinal intolerance. Absorption of amoxicillin/clavulanate is optimized when administered at the beginning of a meal. Adults: Administer 250 mg/125 mg of amoxicillin/potassium clavulanate per dose orally 3 times daily, every 8 hours. For severe infections and respiratory tract infections, the dose may be increased to 500 mg/125 mg of amoxicillin/potassium clavulanate per dose. For patients with renal impairment, adjust the dose as appropriate according to creatinine clearance. Adults: Dose adjustment is based on the maximum recommended dose of amoxicillin. No dose adjustment is required for patients with a creatinine clearance (CrCl) of 30 mL/min or more. 10 ~ 30 mL/min Administer 250mg/125mg or 500mg/125mg of amoxicillin/potassium clavulanate per dose every 12 hours. 10 mL/min or less Administer 250mg/125mg or 500mg/125mg of amoxicillin/potassium clavulanate per dose every 24 hours. Hemodialysis Administer 250mg/125mg or 500mg/125mg of amoxicillin/potassium clavulanate per dose every 24 hours, with an additional dose during dialysis and a repeat dose at the end of dialysis. (Both serum amoxicillin and clavulanate concentrations decrease.)

Child dose

Children 12 years of age or older or weighing 40 kg or more: Administer 250 mg/125 mg of amoxicillin/potassium clavulanate per dose orally 3 times daily, every 8 hours. For severe infections and respiratory tract infections, the dose may be increased to 500 mg/125 mg of amoxicillin/potassium clavulanate per dose. Children: Reduce the dose using the same method.

Precautions

This medication is a beta-lactam antibiotic and should not be administered to patients with allergies to penicillin or cephalosporin antibiotics. Particularly, caution is required in patients with infectious mononucleosis or lymphocytic leukemia as the risk of rash may increase. Patients with a history of liver dysfunction may experience recurring liver damage, so confirmation is essential before use. Patients with liver impairment should be cautious as liver function may worsen during treatment with this medication. Patients with moderate or severe renal impairment may experience delayed drug elimination, necessitating adjustments in administration intervals. Patients with allergic conditions or hypersensitivity symptoms such as bronchial asthma or skin rash should exercise caution when using this medication. Patients who have difficulty with oral intake, elderly patients, or those in poor general condition may display symptoms of vitamin K deficiency, requiring observation. Patients with gastrointestinal disorders or severe vomiting or diarrhea may have inadequate drug absorption, so caution is advised. Gastrointestinal side effects may include diarrhea, vomiting, abdominal pain, and in severe cases, serious colitis like pseudomembranous colitis may occur. Symptoms of liver dysfunction, jaundice, and hepatitis may arise, so immediate consultation with a physician is necessary if abnormal symptoms occur. Rarely, severe skin allergic reactions or anaphylactic shock may occur, requiring immediate cessation of the medication if allergic symptoms appear. Abnormalities related to blood such as leukopenia, anemia, and thrombocytopenia have been reported, which may necessitate regular blood tests. Central nervous system abnormalities may include dizziness, headaches, and seizures occurring rarely, so caution is needed if symptoms arise. Patients with reduced kidney function are at risk for acute renal failure, hence renal function should be monitored before and after administration. This medication can affect the intestinal flora, potentially reducing the effectiveness of oral contraceptives, therefore women taking the medication should be cautious. Pregnant or breastfeeding women should use this medication cautiously under the guidance of a physician as it may affect the fetus or infant. Children, especially those under 12 years of age or weighing less than 40 kg, have limited experience with this medication, thus its use is not recommended. Elderly patients have a higher risk of adverse reactions due to declining physiological functions, so careful observation and dosage adjustment are necessary. This medication can affect certain clinical tests, such as urine glucose tests, so this should be taken into consideration during testing. In cases of overdose, gastrointestinal symptoms, electrolyte imbalances, renal failure, and seizures may occur, requiring immediate medical treatment.

Side effects

Diarrhea, pseudomembranous colitis, indigestion, stomatitis, gastritis, glossitis, black hairy tongue, nausea, vomiting, loss of appetite, abdominal pain, abdominal bloating, constipation, colonic pain, hyperacidity, melena, dry mouth, acute pancreatitis, candidiasis, antibiotic-induced colitis, severe colitis with bloody stools, elevated AST, elevated ALT, elevated ALP, elevated LDH, elevated serum bilirubin, hepatitis, cholestatic jaundice, itching, erythema multiforme, mucous membrane syndrome, toxic epidermal necrolysis, vesicular exfoliative dermatitis, acute generalized pustular psoriasis, drug reaction associated with eosinophilia and systemic symptoms, angioedema, anaphylaxis, serum sickness-like syndrome, hypersensitivity vasculitis, respiratory distress with bronchospasm, laryngeal edema, anaphylactic shock, reversible leukopenia, reversible thrombocytopenia, hemolytic anemia, anemia, thrombocytopenic purpura, eosinophilia, leukemia, agranulocytosis, lymphopenia, thrombocytosis, bone marrow suppression, prolonged bleeding time, prolonged prothrombin time, mucosal candidiasis, vaginal itching, vaginal burning, increased secretion, anxiety, restlessness, behavioral changes, confusion, drowsiness, insomnia, reversible hyperactivity, dizziness, headache, convulsions, antispasmodic, fever, altered consciousness, aseptic meningitis, acute renal failure, interstitial nephritis, hematuria, stomatitis, symptoms of vitamin K deficiency, symptoms of vitamin B deficiency, linear IgA disease, taste disturbance, malaise, dermatitis, oral edema, stomach ache, electrolyte and fluid imbalance, rash, hyperactivity, drowsiness, renal failure, interstitial cerebral convulsions, hypersensitivity shock

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a cool place between 1 and 25 degrees Celsius. Additionally, it is important to store it in a tightly sealed container to prevent moisture.

Appearance and packaging

Appearance

It is a white or nearly white, oval-shaped film-coated tablet.

Package unit

100 tablets (10 tablets/PTPX10)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.